Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 367

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE: Research Article: An Observational Study of TMS

Carpenter, Linda L., Janicak, Philip G., Aaronson, Scott T., Boyadjis, Terrence, Brock, David G., Cook, Ian A., Dunner, David L., Lanocha, Karl, Solvason, H. Brent, Demitrack, Mark A.·2012·Depression and Anxiety

Abstract

BACKGROUND: Few studies have examined the effectiveness of transcranial magnetic stimulation (TMS) in real-world clinical practice settings. METHODS: Forty-two US-based clinical TMS practice sites treated 307 outpatients with Major Depressive Disorder (MDD), and persistent symptoms despite antidepressant pharmacotherapy. Treatment was based on the labeled procedures of the approved TMS device. Assessments were performed at baseline, week 2, at the point of maximal acute benefit, and at week 6 when the acute course extended beyond 6 weeks. The primary outcome was change in the Clinician Global Impressions-Severity of Illness from baseline to end of acute phase. Secondary outcomes were change in continuous and categorical outcomes on self-report depression scales (9-Item Patient Health Questionnaire [PHQ-9], and Inventory of Depressive Symptoms-Self Report [IDS-SR]). RESULTS: Patients had a mean ± SD age of 48.6 ± 14.2 years and 66.8% were female. Patients received an average of 2.5 (± 2.4) antidepressant treatments of adequate dose and duration without satisfactory improvement in this episode. There was a significant change in CGI-S from baseline to end of treatment (-1.9 ± 1.4, P < .0001). Clinician-assessed response rate (CGI-S) was 58.0% and remission rate was 37.1%. Patient-reported response rate ranged from 56.4 to 41.5% and remission rate ranged from 28.7 to 26.5%, (PHQ-9 and IDS-SR, respectively). CONCLUSION: Outcomes demonstrated response and adherence rates similar to research populations. These data indicate that TMS is an effective treatment for those unable to benefit from initial antidepressant medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/da.21969

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. World Health Organization, 2008, The Global Burden of Disease, 2004 Update
  2. Janicak, 2008, Transcranial magnetic stimulation (TMS) in the treatment of major depression: a comprehensive summary of safety experience from acute and extended exposure and during reintroduction treatment, J Clin Psychiatry, 69, 222, 10.4088/JCP.v69n0208 · DOI · Paper page
  3. Aarre, 2003, Efficacy of repetitive transcranial magnetic stimulation in depression: a review of the evidence, Nord J Psychiatry, 57, 227, 10.1080/08039480310001409 · DOI
  4. Allan, 2011, Transcranial magnetic stimulation in the management of mood disorders, Neuropsychobiology, 64, 163, 10.1159/000328951 · DOI
  5. Burt, 2002, Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis, Int J Neuropsychopharmacol, 5, 73, 10.1017/S1461145702002791 · DOI · Paper page
  6. Couturier, 2005, Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis, J Psychiatry Neurosci, 30, 83
  7. Gross, 2007, Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies, Acta Psychiat Scand, 116, 165, 10.1111/j.1600-0447.2007.01049.x · DOI · Paper page
  8. Herrmann, 2006, Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review, J Clin Psychiatry, 67, 1870, 10.4088/JCP.v67n1206 · DOI
  9. Holtzheimer, 2001, A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression, Psychopharmacol Bulletin, 35, 149
  10. Kozel, 2002, Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation to treat depression, J Psychiatric Prac, 8, 270, 10.1097/00131746-200209000-00003 · DOI · Paper page
  11. Lam, 2008, Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis, Canad J Psychiatry, 53, 621, 10.1177/070674370805300909 · DOI · Paper page
  12. Loo, 2005, A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy, J Aff Disorders, 88, 255, 10.1016/j.jad.2005.08.001 · DOI · Paper page
  13. Martin, 2003, Transcranial magnetic stimulation for treating depression (review), Cochrane Library
  14. McNamara, 2001, Transcranial magnetic stimulation for depression and other psychiatric disorders, Psychol Med, 31, 1141, 10.1017/S0033291701004378 · DOI · Paper page
  15. Schutter, 2009, Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis, Psychol Medicine, 39, 65, 10.1017/S0033291708003462 · DOI · Paper page
  16. Slotema, 2010, Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A Meta-analysis of the efficacy of rTMS in psychiatric disorders, J Clin Psychiatry, 71, 873, 10.4088/JCP.08m04872gre · DOI · Paper page
  17. Sackeim, 2001, The definition and meaning of treatment-resistant depression, J Clin Psychiatry, 16, 10
  18. Bandelow, 2006, What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder, J Clin Psychiatry, 67, 1428, 10.4088/JCP.v67n0914 · DOI · Paper page
  19. Katzelnick, 2011, Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severity, Psychiatric Services, 62, 929, 10.1176/appi.ps.62.8.929 · DOI
  20. Kornstein, 2001, Clinical features of treatment-resistant depression, J Clin Psychiatry, 62, 18
  21. Rush, 2008, Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features, Arch Gen Psychiatry, 65, 870, 10.1001/archpsyc.65.8.870 · DOI · Paper page
  22. O'Reardon, 2007, Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multi-site randomized controlled trial, Biol Psychiatry, 62, 1208, 10.1016/j.biopsych.2007.01.018 · DOI · Paper page
  23. Demitrack, 2009, Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data, Psychopharmacol Bulletin, 42, 5
  24. McDonald, 2011, Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression, Depress Anxiety, 28, 973, 10.1002/da.20885 · DOI
  25. Hadley, 2011, Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting, J ECT, 27, 18, 10.1097/YCT.0b013e3181ce1a8c · DOI
  26. Fitzgerald, 2006, A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression, Am J Psychiatry, 163, 88, 10.1176/appi.ajp.163.1.88 · DOI · Paper page

Cited by

See all 367

Metadata

Authors
Carpenter, L. L., Janicak, P. G., Aaronson, S. T., Boyadjis, T., Brock, D. G., Cook, I. A., Dunner, D. L., Lanocha, K., Solvason, H. B., & Demitrack, M. A.
Venue
Depression and Anxiety
Published
2012-06-11
Volume
29
Issue
7
Pages
587-596
ISSN
1091-4269 (ISSN-L)
OpenAlex
W1642975344
Cited by
367
References
8
FWCI
7.04
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1177 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.